Adult, Brigham Young University, Clinical Trials, Dr. Ghosh, Dr. Ito, Dr. Ohanian, Dr. Romancik, Dr. Watt, Drug, Emory University, Oncology, Pediatric, Rare Disease, The University of Texas MD Anderson Cancer Center, University of Michigan, University of Pittsburgh
Press Release: Five clinical trials impacting blood cancers approved for funding Five clinical trials impacting blood cancers approved for funding Cures Within Reach partnered with Goldman Philanthropic Partnerships, Leukemia Research Foundation and individual donors...
Clinical Trials, Dr. Gordon, Dr. Rower, Dr. Teng, Minority/Underrepresented, Oncology, Pediatric, Rare Disease, Stanford University, The University of Texas MD Anderson Cancer Center, University of Utah
Press Release: Stanford and MD Anderson Researchers Both Win CureAccelerator Live! for Pediatric Rare Diseases Stanford and MD Anderson Researchers Both Win CureAccelerator Live! for Pediatric Rare Diseases Clinical Repurposing Trials in Vascular Malformations and...
Adult, Clinical Trials, DEBRA Chile, Dr. Gordon, Dr. Rower, Dr. Teng, Drug, Minority/Underrepresented, Oncology, Pediatric, Rare Disease, Stanford University, The University of Texas MD Anderson Cancer Center, University of Utah
Press Release: Finalists Announced for Pediatric-Focused CureAccelerator Live! for Rare Diseases 2021 Competition Finalists Announced for Pediatric-Focused CureAccelerator Live! for Rare Diseases 2021 Competition Virtual Pitch Event on June 10 Features 4 Pediatric...
Current Research, Dr. Ohanian, Drug, Oncology, Pediatric, Rare Disease, The University of Texas MD Anderson Cancer Center
Adding Metal Detoxification Drugs to Improve Childhood AML and Other Blood Cancer Outcomes Principal Investigator: Dr. Maro Ohanian Disease: Pediatric, adolescent and young adult Acute Myeloid Leukemia, Myelodysplastic Syndrome and Acute Lymphoblastic Leukemia...
CureAccelerator Live!, Current Research, Dr. Gordon, Drug, Minority/Underrepresented, Oncology, Pediatric, Rare Disease, The University of Texas MD Anderson Cancer Center
Enhancing Treatment Response in Recurrent/Metastatic Osteosarcoma with Hydroxychloroquine Principal Investigator: Dr. Nancy Gordon Disease: Osteosarcoma Research Description: Osteosarcoma (OS) is an orphan disease affecting approximately 400 children and adolescents...
